Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax
This article was originally published in The Gray Sheet
Executive Summary
Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.
You may also be interested in...
Final IRS Device Tax Rule Changes Little From Draft As Industry Focuses On Repeal Effort
Though the IRS final regulation offers some wins for industry, manufacturers continue to seek repeal of the device tax.
Washington Roundup, November-December 2012
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we cover the post-election picture, pending reimbursement reductions for interventional cardiologists, and new guidance on PMA and 510(k) submission reviews.
Post-Election Picture: Near-Term Next Steps To Come
A guide to important health care policies and events expected in the short term, now that campaigning is done.